CAS: 514-61-4; Normethandrone

该化合物是源自睾酮的合成新陈代谢类固醇,其特点是结构改变,在减少和诱因效应的同时强化其新陈代谢特性;该化合物通常用于兽医学,以促进肌肉生长和提高牲畜饲料效率;甲基诺丁酮具有很强的亲和性,有利于其在蛋白合成和肌肉发育中的作用;还因其口服生物利用率而闻名,使其在口服时有效;然而,它与许多代谢类固醇一样,具有重大的副作用,包括荷尔蒙不平衡和潜在的肝脏毒性;在许多国家,由于对体育滥用和潜在健康风险的关切,该化合物的使用受到管制.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号434-22-0 诺龙 | CAS号734-32-7 甲基双酮 | CAS号2863-88-9 3-ethoxy-3,5-es... | CAS号75-16-1 甲基溴化镁 | CAS号5696-57-1 3,3-ethanediyld... | CAS号302-76-1 甲雌二醇 | CAS号7100-20-1 17α-methyl-11α,... | CAS号153-23-1 Gona-4,13-dien-...

合成工艺路线路线简述

    📜Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于盐酸,氨,Lithium体系中,化学反应生成 甲基诺龙
    参考文献:Steroids. Liv.1 Synthesis Of 19-Nov-17α-Ethynyltestosterone And 19-Nor-17α-Methyltestosterone2
    标题:Steroids. Liv.1 Synthesis Of 19-Nov-17α-Ethynyltestosterone And 19-Nor-17α-Methyltestosterone2
    摘要:
    DOI:10.1021/ja01645A010

    海关参考信息

    专利信息


    专利号:WO-2014067127-A1
    优先权日:2012-11-02
    标题 :Method for synthesis of 6-methyl-17α-acetoxy-19-norpregn-4,6-diene-3,20-dione
    发明人:HUANG YUNSHENG; XIA QIU; LU HELIN; ZHU YAN; WU TIE; CAO LIN
    权利人:HUANG YUNSHENG; XIA QIU; LU HELIN; ZHU YAN; WU TIE; CAO LIN
    摘要:The present invention relates to a field of compound synthesis and specifically to novel method for the synthesis of 6-methyl-17α-acetoxy-19-norpregn-4,6-diene-3,20-dione. According to the method, norethisterone is used as the starting material to prepare 6-methyl-17α-acetoxy-19-norpregn-4,6-diene-3,20-dione. The method overcomes the defects in the prior art, simplifies the operation and reduces the production cost. The reaction operations are simple, yields are high, and the yield of each step is greater than or equal to 80%.

    专利号:US-2025281509-A1
    优先权日:2021-04-26
    标 题 :Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancer
    发明人:DENMEADE SAMUEL R; ISAACS JOHN T; ANTONARAKIS EMMANUEL S; KACHHAP SUSHANT; MARKOWSKI MARK CHRISTOPHER
    权利人:UNIV JOHNS HOPKINS
    摘要:Disclosed are methods for treating men with castrate resistant prostate cancer with a sufficient dose of testosterone to achieve supraphysiologic serum levels of testosterone in sequence with androgen ablative treatment or androgen synthesis inhibitors for one or more cycles until evidence of radiographic progression, at which point the subject will receive immune checkpoint blockade therapy.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:21 CFR Sections 1308.11-1308.15
    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    参考文献:10.1210/jcem-18-10-1137
    摘要:SEELEN JC. COMPLICATIONS DURING ADMINISTRATION OF METHYLESTRENOLONE. The Journal of Clinical Endocrinology & Metabolism. 1958 Oct;18(10):1137–8. doi: 10.1210/jcem-18-10-1137.
    摘要:SEELEN JC, VERSCHURE JC. [A case of habitual abortion treated with methylestrenolone (orgasterone)]. Ned Tijdschr Verloskd Gynaecol. 1958;58(3-4):285–94.
    参考文献:10.1530/acta.0.0290238
    摘要:HUIS IN 'T VELD LG, VAN DER SPEK PA. The effect of 17 alpha-methyl-19-nortestosterone on the excretion of neutral 17-ketosteroids and 17-hydroxycorticosteroids in adult males. Acta Endocrinol (Copenh). 1958 Oct;29(2):238–52. doi: 10.1530/acta.0.0290238.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知